» Articles » PMID: 35542267

Metabolomics Biotechnology, Applications, and Future Trends: a Systematic Review

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 11
PMID 35542267
Authors
Affiliations
Soon will be listed here.
Abstract

Given the highly increased incidence of human diseases, a better understanding of the related mechanisms regarding endogenous metabolism is urgently needed. Mass spectrometry-based metabolomics has been used in a variety of disease research areas. However, the deep research of metabolites remains a difficult and lengthy process. Fortunately, mass spectrometry is considered to be a universal tool with high specificity and sensitivity and is widely used around the world. Mass spectrometry technology has been applied to various basic disciplines, providing technical support for the discovery and identification of endogenous substances in living organisms. The combination of metabolomics and mass spectrometry is of great significance for the discovery and identification of metabolite biomarkers. The mass spectrometry tool could further improve and develop the exploratory research of the life sciences. This mini review discusses metabolomics biotechnology with a focus on recent applications of metabolomics as a powerful tool to elucidate metabolic disturbances and the related mechanisms of diseases.

Citing Articles

Optimization of Liquid Fermentation of Leaves and Its Non-Targeted Metabolomics Analysis.

Zhang R, Wang X, Xue J, Li X, Li Y, Ding Y Molecules. 2024; 29(19).

PMID: 39407675 PMC: 11478309. DOI: 10.3390/molecules29194749.


Serum metabolites and hypercholesterolemia: insights from a two-sample Mendelian randomization study.

Wang W, Qiao J, Su Z, Wei H, Wu J, Liu Y Front Cardiovasc Med. 2024; 11:1410006.

PMID: 39171325 PMC: 11337230. DOI: 10.3389/fcvm.2024.1410006.


Analysis types and quantification methods applied in UHPLC-MS metabolomics research: a tutorial.

Beger R, Goodacre R, Jones C, Lippa K, Mayboroda O, ONeill D Metabolomics. 2024; 20(5):95.

PMID: 39110307 PMC: 11306277. DOI: 10.1007/s11306-024-02155-6.


Early Metabolomic and Immunologic Biomarkers as Prognostic Indicators for COVID-19.

Chen Z, Fung E, Wong C, Ling L, Lui G, Lai C Metabolites. 2024; 14(7).

PMID: 39057703 PMC: 11278819. DOI: 10.3390/metabo14070380.


Untargeted Metabolomics Based on Ultra-High-Performance Liquid Chromatography Coupled with Quadrupole Orbitrap High-Resolution Mass Spectrometry for Differential Metabolite Analysis of Pinelliae Rhizoma and Its Adulterants.

Wang J, Cui J, Liu Z, Yang Y, Li Z, Liu H Molecules. 2024; 29(9).

PMID: 38731650 PMC: 11085193. DOI: 10.3390/molecules29092155.


References
1.
Liu X, Zhang A, Fang H, Li M, Song Q, Su J . Serum metabolomics strategy for understanding the therapeutic effects of Yin-Chen-Hao-Tang against Yanghuang syndrome. RSC Adv. 2022; 8(14):7403-7413. PMC: 9078382. DOI: 10.1039/c7ra11048k. View

2.
Sun H, Zhang A, Wang X . Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine. Phytother Res. 2012; 26(10):1466-71. DOI: 10.1002/ptr.4613. View

3.
Yang G, Zhao G, Zhang J, Gao S, Chen T, Ding S . Global urinary metabolic profiling of the osteonecrosis of the femoral head based on UPLC-QTOF/MS. Metabolomics. 2019; 15(3):26. DOI: 10.1007/s11306-019-1491-8. View

4.
Zhang A, Sun H, Yan G, Yuan Y, Han Y, Wang X . Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods. J Physiol Biochem. 2013; 70(1):117-28. DOI: 10.1007/s13105-013-0286-z. View

5.
Xu S, Hu C, Hussain S, Tan Q, Wu S, Sun X . Metabolomics analysis reveals potential mechanisms of tolerance to excess molybdenum in soybean seedlings. Ecotoxicol Environ Saf. 2018; 164:589-596. DOI: 10.1016/j.ecoenv.2018.08.062. View